AustralianSuper Pty Ltd Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AustralianSuper Pty Ltd trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.6% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 12,161 shares of the medical equipment provider's stock after selling 725 shares during the period. AustralianSuper Pty Ltd's holdings in Intuitive Surgical were worth $6,023,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Castleark Management LLC boosted its position in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after purchasing an additional 2,990 shares during the period. Arlington Trust Co LLC lifted its stake in Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC lifted its stake in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after purchasing an additional 78 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth $454,000. Finally, Whalerock Point Partners LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $209,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares in the company, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,998 shares of company stock valued at $2,611,577. Corporate insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent research reports. Truist Financial cut their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $566.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, July 14th. Royal Bank Of Canada cut their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Evercore ISI lifted their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $592.86.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $2.46 during trading on Friday, reaching $518.62. The company's stock had a trading volume of 1,903,997 shares, compared to its average volume of 1,666,315. The business's fifty day moving average price is $535.90 and its 200-day moving average price is $536.21. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The firm has a market cap of $185.88 billion, a price-to-earnings ratio of 76.04, a P/E/G ratio of 5.50 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business earned $1.50 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.